PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons

Related Articles
Design and Evolution: Molecular Sleuthing Reveals Drug Selectivity
June 2015
Families in Gene Neighborhoods
June 2015
Ryanodine Receptor
April 2015
CCR5 and HIV Infection
January 2015
Drug Targets: Bile Acids in Motion
September 2014
Drug Targets: S1R's Ligands and Partners
September 2014
P2Y Receptors and Blood Clotting
September 2014
Bacterial CDI Toxins
June 2014
Glucagon Receptor
April 2014
March 2014
Microbial Pathogenesis: Targeting Drug Resistance in Mycobacterium tuberculosis
February 2014
Design and Discovery: Virtual Drug Screening
January 2014
Cancer Networks: IFI16-mediated p53 Activation
November 2013
G Proteins and Cancer
November 2013
Drug Discovery: Antidepressant Potential of 6-NQ SERT Inhibitors
October 2013
Drug Discovery: Finding Druggable Targets
October 2013
Drug Discovery: Identifying Dynamic Networks by CONTACT
October 2013
Drug Discovery: Modeling NET Interactions
October 2013
Membrane Proteome: GPCR Substrate Recognition and Functional Selectivity
August 2013
Infectious Diseases: Determining the Essential Structome
May 2013
NDM-1 and Antibiotics
May 2013
Microbial Pathogenesis: Computational Epitope Prediction
January 2013
Microbial Pathogenesis: Influenza Inhibitor Screen
January 2013
Microbial Pathogenesis: Measles Virus Attachment
January 2013
Cytochrome Oxidase
November 2012
Membrane Proteome: The ABCs of Transport
November 2012
Bacterial Phosphotransferase System
October 2012
Regulatory insights
September 2012
Solute Channels
September 2012
Pocket changes
July 2012
Receptor bias
July 2012
Anthrax Stealth Siderophores
June 2012
G Protein-Coupled Receptors
May 2012
Substrate specificity sleuths
April 2012
Reading out regioselectivity
December 2011
Superbugs and Antibiotic Resistance
December 2011
Terminal activation
December 2011
A change to resistance
November 2011
Docking and rolling
October 2011
Breaking down the defenses
September 2011
A2A Adenosine Receptor
May 2011
Cell wall recycler
May 2011
Subtly different
March 2011
January 2011
Subtle shifts
January 2011
ABA receptor diversity
November 2010
COX inhibition: Naproxen by proxy
November 2010
Zinc Transporter ZntB
July 2010
Peptidoglycan binding: Calcium-free killing
June 2010
Treating sleeping sickness
May 2010
Bacterial spore kinase
April 2010
Antibiotics and Ribosome Function
March 2010
Safer Alzheimer's drugs?
March 2010
Anthrax evasion tactics
September 2009
GPCR subunits: Separate but not equal
September 2009
Antibiotic target
August 2009
Salicylic Acid Binding Protein 2
August 2009
July 2009
Tackling influenza
June 2009
Bacterial Leucine Transporter, LeuT
May 2009
Anthrax stealth molecule
March 2009
Drug targets to aim for
February 2009
High-energy storage system
February 2009
Transporter mechanism in sight
February 2009
Scavenger Decapping Enzyme DcpS
November 2008
Blocking AmtB
September 2008

Research Themes Drug discovery


SBKB [doi:10.3942/psi_sgkb/fm_2011_1]
Featured System - January 2011
Short description: The GPCR (G protein-coupled receptor) community is suffering from an embarrassment of riches.

3emm The GPCR (G protein-coupled receptor) community is suffering from an embarrassment of riches. For many years, structure-based studies relied on atomic structures of rhodopsin, and research was forced to extrapolate from these using homology models. But in the past few years, PSI researchers have revolutionized the field with new structures and new insights. A collection of five structures of CXCR4, solved by a team of researchers at the PSI GPCR network, is the most recent installment in this exciting story.

Signaling in Health and Disease

CXCR4 is a chemokine receptor that regulates the migration of cells in the immune system. Chemokine receptors typically interact with a variety of chemokines, but CXCR4 is an exception, and is specific for the chemokine CXCL12. Together, they normally play an essential role in the development of blood cells, but they are also important in disease. For instance, communication through CXCR4 may promote the many pathological changes in cancer cells, including formation of metastases and abnormal growth of blood vessels. CXCR4 also plays a central role in infection by HIV, since it is the co-receptor that guides the virus into cells.

CXCR4 in Action

The structure of CXCR4 revealed the signature core of GPCRs: a bundle of seven alpha helices that criss-cross through the cell membrane. These are connected by a series of loops that are exposed on the two sides of the membrane and perform much of the work of recognizing the chemokine and passing the signal inside. The binding site is a cup-shaped depression on the outer surface. Crystal structures were obtained with a large cyclic peptide bound in the active site (shown at the top here from PDB entry 3oe0), suggesting how the chemokine might bind, and also with a small inhibitor bound (shown below from PDB entry 3odu), providing a place to start for design of anti-HIV drugs.

Solving the Structure

Membrane proteins are always challenging targets for crystallography, because they need to be separated from their comfortable membrane environment. CXCR4 is no exception, so in order to solve the structure, the PSI team engineered a more cooperative form of the receptor. They clipped one of the intracellular loops of the receptor and inserted an entire molecule of lysozyme. The two-part protein folds correctly, is still active as a receptor, and with some coaxing, forms high-quality crystals for structure solution. To look at these structures in more detail, the JSmol tab below displays an interactive JSmol.

The JSmol tab below displays an interactive JSmol

Nitrile Reductase QueF (PDB entry 3bp1)

This computational model shows two subunits of QueF (in blue and turquoise), with NADPH (magenta) and a nitrile-modified guanine base (green) in the active site groove. The catalytic cysteines are shown with yellow sulfur atoms. Use the buttons to compare the modeled structure of NADPH with the experimentally-observed positions of guanine and pyrophosphate, and to view all of the atoms in the protein.


  1. Wu, B. et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066-1071 (2010).

  2. Alkhatib, G. The biology of CCR5 and CXCR4. Curr. Op. HIV AIDS 4, 96-103 (2009).

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health